Clinics of Oncology
About Us
Author Guidelines
Contact
Editor in Chief
Editorial Board
Home
Peer Review Process
Submit Manuscript
Terms & Conditions
Volumes
Severe Ocular Adverse Reaction Following Single Pembrolizumab Infusion: A Case Report
Jul 20, 2024
—
by
kiransyapu@gmail.com
in
Featured
,
Volume 7
http://doi.org/10.47829/COO.2024.71201
←
Previous:
Thalidomide Improve Outcomes as Maintenance Therapy in Peripheral T- Celll Lymphoma
Next:
Enhancing Industrial Safety and Health Education: Bridging Gaps for Safer Workplaces and Organizational Resilience
→
error:
Content is protected !!